27
Views
5
CrossRef citations to date
0
Altmetric
Miscellaneous

Future therapies for schizophrenia

&
Pages 151-165 | Published online: 25 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Monsheel Sodhi, Kimberly H Wood & James Meador-Woodruff. (2008) Role of glutamate in schizophrenia: integrating excitatory avenues of research. Expert Review of Neurotherapeutics 8:9, pages 1389-1406.
Read now
Mark A Sanner. (1998) Selective dopamine D4 receptor antagonists. Expert Opinion on Therapeutic Patents 8:4, pages 383-393.
Read now

Articles from other publishers (3)

Bob Wilffert, Rianne Zaal & Jacobus R.B.J. Brouwers. (2005) Pharmacogenetics as a tool in the therapy of schizophrenia. Pharmacy World & Science 27:1, pages 20-30.
Crossref
Sanober Shaikh & Robert W. Kerwin. (2002) Receptor pharmacogenetics: relevance to CNS syndromes. British Journal of Clinical Pharmacology 54:4, pages 344-348.
Crossref
A.A Bolonna, M.J Arranz, J Munro, S Osborne, M Petouni, M Martinez & R.W Kerwin. (2000) No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response. Neuroscience Letters 280:1, pages 65-68.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.